This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Biogen Inc. slipped 2.9% to $124.99 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 6,296.79 and the Dow Jones Industrial Average falling 0.3% to 44,342.19.
The stock's fall snapped a two-day winning streak.
Biogen Inc. closed 47.1% below its 52-week high of $236.48, which the company achieved on July 25th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson rose 0.4% to $163.70, Pfizer Inc. fell 0.4% to $24.47, and AbbVie Inc. fell 1.12% to $189.26.
Trading volume totaled 1.5 million, compared to the 50-day average of 1.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 18, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.